
    <!DOCTYPE html>
    <html>
    <head>
        <style>
            body { 
                font-family: 'Segoe UI', Roboto, -apple-system, sans-serif; 
                max-width: 1200px; 
                margin: 0 auto; 
                padding: 20px; 
                background-color: #f0f2f5;
                line-height: 1.6;
            }
            .container { 
                background-color: white; 
                padding: 40px; 
                border-radius: 16px; 
                box-shadow: 0 4px 12px rgba(0,0,0,0.1);
            }
            .agent-section { 
                margin-bottom: 35px; 
                padding: 25px; 
                border-radius: 12px; 
                transition: all 0.3s ease;
            }
            .agent-section:hover {
                transform: translateY(-2px);
                box-shadow: 0 4px 15px rgba(0,0,0,0.1);
            }
            .final-annotation { 
                background-color: #f0f7ff; 
                border-left: 5px solid #2196f3; 
            }
            .validator { 
                background-color: #f0fdf4; 
                border-left: 5px solid #22c55e; 
            }
            .formatting { 
                background: linear-gradient(145deg, #fff7ed, #ffe4c4);
                border-left: 5px solid #f97316; 
                box-shadow: 0 4px 15px rgba(249, 115, 22, 0.1);
            }
            h2 { 
                color: #1a2b3c; 
                margin-top: 0; 
                font-size: 1.5rem;
                font-weight: 600;
                display: flex;
                align-items: center;
                gap: 10px;
            }
            ul { 
                margin: 15px 0; 
                padding-left: 20px; 
            }
            pre { 
                background-color: #f8fafc; 
                padding: 20px; 
                border-radius: 8px; 
                overflow-x: auto;
                font-family: 'Consolas', 'Monaco', monospace;
                font-size: 0.9rem;
                line-height: 1.5;
            }
            .validation-result { 
                font-weight: 600; 
                color: #16a34a; 
                padding: 12px 20px;
                background-color: #dcfce7; 
                border-radius: 8px; 
                display: inline-block;
                margin: 10px 0;
            }
            br { 
                margin-bottom: 8px; 
            }
            p {
                margin: 12px 0;
                color: #374151;
            }
            .summary-content {
                display: flex;
                flex-direction: column;
                gap: 24px;
            }
            .summary-item {
                display: flex;
                flex-direction: column;
                gap: 8px;
                background: rgba(255, 255, 255, 0.7);
                padding: 16px;
                border-radius: 12px;
                backdrop-filter: blur(8px);
                box-shadow: 0 2px 8px rgba(0, 0, 0, 0.05);
            }
            .summary-label {
                font-weight: 600;
                color: #c2410c;
                font-size: 0.95rem;
                text-transform: uppercase;
                letter-spacing: 0.5px;
            }
            .summary-value {
                color: #1f2937;
                font-size: 1.1rem;
                padding: 8px 16px;
                background-color: rgba(255, 255, 255, 0.9);
                border-radius: 8px;
                display: inline-block;
                box-shadow: 0 1px 3px rgba(0, 0, 0, 0.1);
            }
            .summary-list {
                margin: 0;
                padding-left: 24px;
                list-style-type: none;
            }
            .summary-list li {
                color: #1f2937;
                padding: 8px 0;
                position: relative;
            }
            .summary-list li:before {
                content: "‚Ä¢";
                color: #f97316;
                font-weight: bold;
                position: absolute;
                left: -20px;
            }
            .report-header {
                text-align: center;
                margin-bottom: 40px;
                padding-bottom: 30px;
                border-bottom: 2px solid rgba(249, 115, 22, 0.2);
            }
            
            .report-title {
                font-size: 2.5rem;
                font-weight: 800;
                color: #1a2b3c;
                margin: 0;
                padding: 0;
                background: linear-gradient(135deg, #f97316, #c2410c);
                -webkit-background-clip: text;
                -webkit-text-fill-color: transparent;
                letter-spacing: -0.5px;
            }
            
            .report-subtitle {
                font-size: 1.1rem;
                color: #64748b;
                margin-top: 8px;
                font-weight: 500;
            }
            .scoring { 
                background: linear-gradient(145deg, #f0fdf4, #dcfce7);
                border-left: 5px solid #22c55e;
                box-shadow: 0 4px 15px rgba(34, 197, 94, 0.1);
            }
            .scoring-content {
                display: flex;
                flex-direction: column;
                gap: 16px;
                color: #1f2937;
                line-height: 1.8;
            }
            .scoring-content br + br {
                content: "";
                display: block;
                margin: 12px 0;
            }
            .empty-list {
                color: #6b7280;
                font-style: italic;
            }
            .error-message {
                color: #dc2626;
                padding: 12px;
                background-color: #fef2f2;
                border-radius: 6px;
                border-left: 4px solid #dc2626;
            }
            .score-badge {
                background: linear-gradient(135deg, #22c55e, #16a34a);
                color: white;
                padding: 8px 16px;
                border-radius: 12px;
                font-size: 1.5rem;
                font-weight: 700;
                display: inline-block;
                margin: 12px 0;
                box-shadow: 0 4px 12px rgba(34, 197, 94, 0.2);
                position: relative;
                top: -10px;
            }
            .score-badge::before {
                content: "Score:";
                font-size: 0.9rem;
                font-weight: 500;
                margin-right: 8px;
                opacity: 0.9;
            }
        </style>
    </head>
    <body>
        <div class="container">
            <div class="report-header">
                <h1 class="report-title">CASSIA Analysis Report</h1>
                <p class="report-subtitle">Comprehensive Cell Type Analysis and Annotation</p>
            </div>
            
                <div class="agent-section final-annotation">
                    <h2>üîç Final Annotation Analysis</h2>
                    To annotate the cell type based on the provided ranked marker list from a single-cell human dataset derived from breast cancer tissue, I will follow the outlined steps:<br><br>### Step 1: List the Key Functional Markers<br>- **Collagens (COL1A1, COL1A2, COL3A1, COL11A1, COL5A1, COL5A2, COL12A1, COL6A3, COL6A2, COL6A1, COL10A1, COL8A1):** These are structural proteins that form the extracellular matrix (ECM) and provide structural support to tissues.<br>- **Matrix Metalloproteinases (MMP11, MMP2, MMP14):** Enzymes that degrade various components of the ECM, involved in tissue remodeling and cancer metastasis.<br>- **Integrins (ITGA11):** Receptors that mediate cell-ECM adhesion, playing a role in cell signaling and migration.<br>- **Fibronectin (FN1):** A glycoprotein involved in cell adhesion and migration processes.<br>- **Periostin (POSTN):** A matricellular protein involved in tissue repair and remodeling.<br>- **Thrombospondin (THBS2):** Involved in cell-to-cell and cell-to-matrix communication.<br>- **Decorin (DCN), Lumican (LUM), Biglycan (BGN):** Small leucine-rich proteoglycans involved in collagen fibrillogenesis and ECM organization.<br>- **Fibulin (FBLN2):** Involved in the stabilization of ECM structures.<br>- **Versican (VCAN):** A large chondroitin sulfate proteoglycan involved in cell adhesion, proliferation, and migration.<br>- **Cathepsin K (CTSK):** A protease involved in bone resorption and ECM degradation.<br>- **Insulin-like Growth Factor Binding Protein 7 (IGFBP7):** Modulates IGF signaling and is involved in cell adhesion and migration.<br><br>### Step 2: List the Key Cell Type Markers<br>- **PDGFRB (Platelet-Derived Growth Factor Receptor Beta):** A marker for pericytes and fibroblasts, involved in cell proliferation and migration.<br>- **THY1 (CD90):** A marker for fibroblasts and mesenchymal stem cells.<br>- **ADAMTS2 (A Disintegrin and Metalloproteinase with Thrombospondin Motifs 2):** Involved in the processing of collagen precursors, associated with fibroblasts.<br>- **SPARC (Secreted Protein Acidic and Rich in Cysteine):** A matricellular protein associated with fibroblasts and involved in ECM remodeling.<br>- **AEBP1 (Adipocyte Enhancer-Binding Protein 1):** Associated with fibroblasts and involved in ECM organization.<br><br>### Step 3: Cross-reference Known Databases<br>Using scRNA-seq databases such as the Human Cell Atlas and literature on breast cancer stroma, the markers listed are predominantly associated with fibroblasts, particularly cancer-associated fibroblasts (CAFs), which are known to play a significant role in the tumor microenvironment by remodeling the ECM and influencing cancer progression.<br><br>### Step 4: Determine the Most Probable General Cell Type<br>Based on the expression of these markers, the most likely general cell type of the cluster is **fibroblasts**. The presence of multiple collagen genes, ECM-related proteins, and fibroblast-specific markers strongly supports this annotation.<br><br>### Step 5: Identify the Top 3 Most Probable Sub Cell Types<br>1. **Cancer-Associated Fibroblasts (CAFs):** Given the context of breast cancer tissue and the expression of ECM remodeling enzymes and proteins, CAFs are the most likely subtype.<br>2. **Myofibroblasts:** Characterized by ECM production and contractile activity, often found in tumor stroma.<br>3. **Pericyte-like Fibroblasts:** Express PDGFRB and are involved in vascular support and ECM production.<br><br>The most likely subtype based on the markers is **Cancer-Associated Fibroblasts (CAFs)** due to their prominent role in the tumor microenvironment and the expression of markers involved in ECM remodeling and interaction with cancer cells.<br><br>### Step 6: Provide a Concise Summary of Your Analysis<br>The analysis of the ranked marker list from the breast cancer tissue dataset suggests that the cell cluster is composed of fibroblasts, with a high likelihood of being cancer-associated fibroblasts (CAFs). This is supported by the expression of multiple collagen genes, ECM-related proteins, and fibroblast-specific markers, which are characteristic of CAFs involved in the tumor microenvironment.<br><br>**FINAL ANNOTATION COMPLETED**
                </div>
            
                <div class="agent-section validator">
                    <h2>‚úì Validation Check</h2>
                    <div class="validation-result">‚úÖ VALIDATION PASSED</div>
                    Validation result: VALIDATION PASSED<br><br>The proposed annotation result is consistent with the provided marker list and the context of breast cancer tissue. Here's the breakdown of the validation:<br><br>1. **Marker Consistency:**<br>   - The markers listed in the annotation result are present in the provided marker list.<br>   - The markers are consistent with the identification of fibroblasts, particularly cancer-associated fibroblasts (CAFs). Key markers such as collagens (COL1A1, COL1A2, COL3A1), matrix metalloproteinases (MMP11, MMP2, MMP14), and fibroblast-specific markers (PDGFRB, THY1, SPARC, AEBP1) strongly support the annotation of fibroblasts and CAFs.<br><br>2. **Mixed Cell Type Consideration:**<br>   - The annotation considers potential subtypes within the fibroblast category, such as myofibroblasts and pericyte-like fibroblasts, which is appropriate given the complexity of the tumor microenvironment.<br>   - There is no strong evidence of multiple distinct cell types outside the fibroblast lineage, so the annotation does not require flagging for mixed cell types.<br><br>The annotation of the cell cluster as fibroblasts, with a high likelihood of being cancer-associated fibroblasts (CAFs), is well-supported by the marker list and the context of breast cancer tissue.
                </div>
            
                        <div class="agent-section formatting">
                            <h2>üìã Summary</h2>
                            
                        <div class="summary-content">
                            <div class="summary-item">
                                <span class="summary-label">Main Cell Type:</span>
                                <span class="summary-value">fibroblasts</span>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Sub Cell Types:</span>
                                <ul class="summary-list">
                                    <li>Cancer-Associated Fibroblasts (CAFs)</li><li>Myofibroblasts</li><li>Pericyte-like Fibroblasts</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Possible Mixed Cell Types:</span>
                                <ul class="summary-list">
                                    <li class="empty-list">No mixed cell types identified</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Number of Markers:</span>
                                <span class="summary-value">50</span>
                            </div>
                        </div>
                    
                        </div>
                    
                    <div class="agent-section scoring">
                        <h2>üéØ Quality Assessment</h2>
                        <div class="score-badge">90</div>
                        <div class="scoring-content">
                            The annotation results provided for the single-cell dataset derived from human breast cancer tissue are generally well-executed, with a strong focus on identifying fibroblasts, particularly cancer-associated fibroblasts (CAFs). The analysis effectively utilizes a comprehensive list of markers, including collagens, matrix metalloproteinases, and fibroblast-specific markers, to support the annotation of fibroblasts. This is scientifically accurate given the context of breast cancer tissue, where CAFs play a significant role in the tumor microenvironment.<br><br>Strengths:<br>1. **Correctness of Annotations**: The identification of fibroblasts, especially CAFs, is well-supported by the expression of multiple collagen genes and ECM-related proteins. The inclusion of markers like PDGFRB, THY1, and SPARC further strengthens the annotation as these are commonly associated with fibroblasts.<br>2. **Balanced Consideration of Markers**: The analysis does not overly focus on a single marker but rather considers a wide range of markers that are relevant to fibroblasts and ECM remodeling. This balanced approach helps in capturing the complexity of the cell population.<br>3. **Comprehensive View**: The annotation provides a clear picture of the cell types present, considering potential subtypes such as myofibroblasts and pericyte-like fibroblasts. This reflects an understanding of the heterogeneity within the fibroblast population in the tumor microenvironment.<br><br>Weaknesses:<br>1. **Marker Rank Consideration**: While the analysis is thorough, it could have placed more emphasis on the rank of the markers. For instance, the presence of highly ranked markers like COL1A1 and COL1A2 should have been highlighted more prominently as they are critical in defining the ECM and fibroblast identity.<br>2. **Potential Oversights**: Although the annotation is robust, there is a slight risk of overlooking other cell types that might be present in the dataset. However, given the strong fibroblast signature, this is a minor concern.<br><br>Overall, the annotation is scientifically sound and provides a comprehensive view of the cell populations, with a strong focus on fibroblasts and their subtypes. The analysis effectively captures the general picture of the data, with only minor areas for improvement in marker rank consideration.<br>
                        </div>
                    </div>
                
        </div>
    </body>
    </html>
    